For the latest updates on how we are managing changes due to COVID-19 please click here.

Resources

Articles

January, 2021

White Paper: Conducting Safe and Effective Clinical Trials in the COVID-19 Environment

Read More »
December, 2020

Increasing Your Practice’s Reach, Relevance, and Revenue with Clinical Trials

Read More »
November, 2020

White Paper: The Patient Perspective on Living with Glaucoma

Read More »


View All Articles


News

December, 2020

Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease

Read More »
December, 2020

Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients with Dry Eye Disease

Read More »
December, 2020

Novaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease

Read More »


View All News


Tags